🧪Multiomics & machine learning are transforming how we predict, detect & treat atherosclerosis. Integrating genomics, proteomics, metabolomics, & more is paving the way to personalized cardiovascular care. Check out this #PharmRev paper to learn more: https://ow.ly/H41550YoMJt
#pharmsky
Adenosine-driven immunosuppression remains a barrier in cancer therapy. Targeting adenosine A2A/A2B receptors offers a path to reprogram the tumor microenvironment and boost immunotherapy efficacy. Read more of this exciting new #PharmRev publication here: https://ow.ly/95rZ50Yfjxj 🧪
Adenosine-driven immunosuppression remains a barrier in cancer therapy. Targeting adenosine A2A/A2B receptors offers a path to reprogram the tumor microenvironment and boost immunotherapy efficacy. Read more of this exciting new #PharmRev publication here: https://ow.ly/95rZ50Yfjxj 🧪
This exciting #PharmRev article takes an in-depth look at recent developments in the discovery and clinical significance of pharmacological agents targeting mammalian TRP channels: https://ow.ly/Xnov50YetJQ 🧪
#Cardiovascular diseases remain the leading cause of death worldwide, with lipid-lowering drugs playing a key role in risk management. This review dives into the evolution of lipid-lowering treatments: https://ow.ly/sXkl50Y5u7W
#PharmRev 🧪
Check out this recent #PharmRev review to explore the use of metal-based agents conjugated to tumor-targeting molecules for the treatment of #breastcancer.
Read the research: pharmrev.aspetjournals.org/article/S0031-6997(25)07...
Modern antidiabetic drugs do more than lower sugar, they protect the heart and vessels. This review explains how. #PharmRev 🧪
https://ow.ly/nZLt50XMvsO
Neuropeptides fine-tune the brain’s noradrenergic centre. This review maps how they regulate the locus coeruleus to shape behaviour. #PharmRev Danai Riga 🧪
https://ow.ly/SrCq50XMrCq
Posttraumatic epilepsy remains untreatable. This review highlights new models and strategies for PTE prevention and therapy. #PharmRev #Epilepsy 🧪
https://ow.ly/EHRR50XMrre
EPAC proteins reshape blood vessels. This review dissects cAMP-driven vascular remodeling and its therapeutic implications. #PharmRev #science 🧪
pharmrev.aspetjournals.org/article/S0031-6997(25)07...
Reprogramming cells to heal organs, this review explores breakthroughs in cell and tissue reprogramming for regenerative drug discovery. #PharmRev 🧪
https://ow.ly/9KGW50XMnLp
The complement system is booming, 8 new drugs in 5 years! This review covers the biology, pathology, and therapeutic targeting of complement pathways. #PharmRev @neurocomplementlab.bsky.social 🧪
https://ow.ly/Tolg50XL5V5
📢 Hypoxia fuels tumor survival. This review from Gregg Semenza explores small-molecule inhibitors of HIF-1/2 as emerging cancer therapeutics. #PharmRev 🧪
https://ow.ly/jENZ50XJOVj
EGFR drives many cancers, but resistance remains a challenge. This review decodes EGFR biology and emerging strategies to overcome therapy resistance. #PharmRev #cancertherapy #science 🧪
https://ow.ly/IiMg50XHqHK
Targeting serotonin to treat neurodegeneration: this review explores how the serotonergic system could unlock new therapies for Alzheimer’s, Parkinson’s, and ALS. #PharmRev #Neuroscience #science 🧪
https://ow.ly/xK4z50XHqhf
Dopamine doesn’t just drive reward; it guides our social lives. This review explores how dopamine regulates social behaviour across species. #PharmRev #Dopamine Nancy Padilla-Coreano Martínez-Rivera 🧪
https://ow.ly/hx0x50XARUX
